An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Public ClinicalTrials.gov record NCT07033026. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia
Study identification
- NCT ID
- NCT07033026
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NGM Biopharmaceuticals, Inc
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Interventions
- NGM120 Q4W Drug
- NGM120 Q8W Drug
- Placebo given Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2025
- Primary completion
- Mar 31, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Mar 31, 2026
2025 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NGM Clinical Study Site | Los Angeles | California | 90033 | Recruiting |
| NGM Clinical Study Site | Los Angeles | California | 90095 | Recruiting |
| NGM Clinical Study Site | Santa Rosa | California | 95403 | Recruiting |
| NGM Clinical Study Site | Margate | Florida | 33063 | Recruiting |
| NGM Clinical Study Site | Baltimore | Maryland | 21201 | Recruiting |
| NGM Clinical Study Site | New York | New York | 10065 | Recruiting |
| NGM Clinical Study Site | Toledo | Ohio | 43608 | Recruiting |
| NGM Clinical Study Site | Youngstown | Ohio | 44504 | Recruiting |
| NGM Clinical Study Site | Dallas | Texas | 75390 | Recruiting |
| NGM Clinical Study Site | Kingwood | Texas | 77339 | Withdrawn |
| NGM Clinical Study Site | Laredo | Texas | 78041 | Recruiting |
| NGM Clinical Study Site | Richmond | Virginia | 23114 | Recruiting |
| NGM Clinical Study Site | Appleton | Wisconsin | 54915 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07033026, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07033026 live on ClinicalTrials.gov.